Dmitry Kulish
Founder
Immunotherapy
Sustainable Resource Engineering
Russian Federation
Biography
SUNY/RAS Ph.D.'98 biochemistry, Harvard postdoc'00 genetics, WHarton MBA'02, mngmt consulting. In 2013 joined Nanolek at the position of Executive Vice President: managed portfolio development, formed a team, signed several big contracts.In 2014 joined Fresenius Kabi Russia as COO responsible for integration of manufacturing and R&D acquisition at Binnopharm. The deal was cancelled due to circumstances beyond control. In 2015 founded Russian pharmaceutical consultancy "DrugDevelopment.Ru"
Research Interest
Pharmaceutics, Therapies
